Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.36 |
| ▸ | FABP7 | O15540 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | CASP3 | P42574 | 3/20 | 0.35 |
| ▸ | MDM4 | O15151 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6513653 | 0.92 | EPHX2 (0.39) | EPHX2FABP5FABP7KMT2ACASP3 | |
| SCHEMBL31342808 | 0.88 | FABP5 (0.39) | EPHX2FABP5FABP7KMT2ACASP3 | |
| SCHEMBL2922121 | 0.88 | FABP5 (0.39) | EPHX2FABP5FABP7KMT2ACASP3 | |
| SCHEMBL4405189 | 0.79 | KEAP1 (0.35) | EPHX2FABP5FABP7KMT2ACASP3 | |
| SCHEMBL1905118 | 0.79 | FABP5 (0.44) | EPHX2FABP5FABP7KMT2ACASP3 | |
| SCHEMBL599683 | 0.79 | FABP5 (0.39) | EPHX2FABP5FABP7KMT2ACASP3 | |
| SCHEMBL29474439 | 0.79 | FABP5 (0.39) | EPHX2FABP5FABP7KMT2ACASP3 | |
| SCHEMBL29763559 | 0.79 | FABP5 (0.39) | EPHX2FABP5FABP7KMT2ACASP3 | |
| SCHEMBL29201750 | 0.79 | FABP5 (0.39) | EPHX2FABP5FABP7KMT2ACASP3 | |
| SCHEMBL2447958 | 0.77 | FABP5 (0.37) | FABP5FABP7KMT2ACASP3MDM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050124535-A1 | Cyclic peptide nanotube structures for molecular scale electronic and photonic devices | WORCESTER POLYTECHNIC INSTITUTE | 2005-06-09 | — | — | US | disclosed |
| US-6902720-B2 | Cyclic peptide structures for molecular scale electronic and photonic devices | WORCESTER POLYTECHNIC INSTITUTE (US) | 2005-06-07 | — | — | US | disclosed |
| US-20030144185-A1 | Cyclic peptide structures for molecular scale electronic and photonic devices | WORCESTER POLYTECHNIC INSTITUTE | 2003-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050124535-A1 | Cyclic peptide nanotube structures for molecular scale electronic and photonic devices | NPPA, NGF, QRFPR | EPHX2 1492/4885FABP5 2096/4885FABP7 1969/4885 |
| US-20030144185-A1 | Cyclic peptide structures for molecular scale electronic and photonic devices | VIP, NPPA, NGLY1 | EPHX2 1439/4885FABP5 991/4885FABP7 707/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.